Robert J. Unwin
AstraZeneca (United Kingdom)(GB)Department of Health and Social Care(GB)University of Zurich(CH)London International Development Centre(GB)The Royal Free Hospital(GB)AstraZeneca (South Korea)(KR)AstraZeneca (Singapore)(SG)AstraZeneca (Brazil)(BR)AstraZeneca (Switzerland)(CH)AstraZeneca (Poland)(PL)AstraZeneca (Finland)(FI)AstraZeneca (Spain)(ES)AstraZeneca (Germany)(DE)Czech Academy of Sciences, Institute of Physiology(CZ)University College London(GB)
Publications by Year
Research Areas
Ion Transport and Channel Regulation, Adenosine and Purinergic Signaling, Electrolyte and hormonal disorders, Biomedical Research and Pathophysiology, Renal function and acid-base balance
Most-Cited Works
- → Human Hypertension Caused by Mutations in WNK Kinases(2001)1,466 cited
- → Heavy metal poisoning: the effects of cadmium on the kidney(2010)731 cited
- → Progression after AKI(2015)407 cited
- → The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension(2011)368 cited
- → Mechanisms of cognitive dysfunction in CKD(2020)362 cited
- → Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene.(1997)361 cited
- → KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron